Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2007

01-11-2007 | Original Paper

Residential Transience and HIV Risk Behaviors Among Injection Drug Users

Authors: Danielle German, Melissa A. Davey, Carl A. Latkin

Published in: AIDS and Behavior | Special Issue 2/2007

Login to get access

Abstract

Housing instability has been linked to HIV risk behaviors. Many studies have focused on the implications of one’s housing structure or lack thereof. This study focuses on residential transience as an additional dimension of housing instability. Specifically, we assessed the associations between transience and four HIV risk behaviors. Transience was defined as moving twice or more in the past six months. Multivariate analyses of a sample of current injectors (n = 807) indicated that transience had an independent effect on HIV risk behaviors. Transient individuals were more likely to share needles and go to a shooting gallery than non-transient individuals. Transience was not associated with exchanging sex or having multiple sex partners when homelessness was included in the models. Further examination of the association between housing and HIV should consider the role of transience. Interventions that promote housing stability among IDUs and address HIV risk during times of instability are needed.
Literature
Aidala, A., Cross, J. E., Stall, R., Harre, D., & Sumartojo, E. (2005). Housing status and HIV risk behaviors: Implications for prevention and policy. AIDS and Behavior, 9, 251–265.PubMedCrossRef
Bartlett, S. (1996). The significance of relocation for chronically poor families in the USA. Environment and Urbanization, 9, 121–130.CrossRef
Bouhnik, A. D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J. P. et al. (2002). Nonadherence among HIV-infected injecting drug users: The impact of social instability. Journal of Acquired Immune Deficiency Syndromes, 31(3), S149–S153.
Browning, C. R., & Cagney, K. A. (2002). Neighborhood structural disadvantage, collective efficacy, and self-rated physical health in an urban setting. Journal of Health and Social Behavior, 43, 383–398.PubMedCrossRef
Browning, C. R., & Cagney, K. (2003). Moving beyond poverty: Neighborhood structure, social processes, and health. Journal of Health and Social Behavior, 44, 552–571.PubMedCrossRef
Carlisle-Frank, P. L. (1992). The relocation experience: Analysis of factors thought to inflluence adjustment to transition. Psychological Reports, 70, 835–838.CrossRef
Corneil, T. A., Kuyper, L. M., Shoveller, J., Hogg, R. S., Li, K., Spittal, P. M., et al. (2006). Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health & Place, 12, 79–85.CrossRef
Cottler, L. B., Compton, W. M. III, Ben Abdallah, A., Horne, M., & Claverie, D. (1996). Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug and Alcohol Dependence, 41, 209–217.PubMedCrossRef
Evans, J. L., Hahn, J. A., Page-Shafer, K., Lum, P. J., Stein, E. S., Davidson, P. J., et al. (2003). Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health, 80, 137–146.PubMedCrossRef
Herdt G. (Eds.). (1997). Sexual cultures and migration in the era of AIDS. Anthropological and demographic perspectives. New York: Oxford University Press.
Institute of Medicine. (1999). Supporting adolescents with social institutions. In M. D. Kipke (Eds.), Risks and Opportunities: Synthesis of Studies on Adolescence (pp. 18–29). Washington, D.C. National Academy Press.
Latkin, C. A., Mandell, W., Knowlton, A. R., Vlahov, D., & Hawkins, W. (1998). Personal network correlates and predictors of homelessness for injection drug users in Baltimore, Maryland. Journal of Social Distress and the Homeless, 7, 263–278.CrossRef
Macalino, G. E., Celentano, D. D., Latkin, C. A., Strathdee, S. A., & Vlahov, D. (2002). Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention, 14, 367–378.PubMedCrossRef
Mehta, S. H., Thomas, D. L., Sulkowski, M. S., Safaein, M., Vlahov, D., & Strathdee, S. A. (2005). A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS, 19(3), S179–S189.
Messiah, A., Navaline, H., Davis-Vogel, A., Tobin-Fiore, D., & Metzger, D. (2003). Sociodemographic and behavioral characteristics associated with timeliness and retention in a 6-month follow-up study of high-risk injection drug users. American Journal of Epidemiology, 157, 930–939.PubMedCrossRef
Metraux, S., Metzger, D. S., & Culhane, D. P. (2004). Homelessness and HIV risk behaviors among injection drug users. Journal of Urban Health, 81, 618–629.PubMed
Paris, N. M., East, R. T., & Toomey, K. E. (1996). HIV seroprevalence among Atlanta’s homeless. Journal of Health Care for the Poor and Underserved, 7, 83–93.PubMed
Parker, R. G., Easton, D., & Klein, C. H. (2000). Structural barriers and facilitators in HIV prevention: A review of international research. AIDS, 14(S1), S22–S32.PubMedCrossRef
Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., et al. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD and AIDS, 8, 437–445.PubMedCrossRef
Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., & Holloway, G. (2006). Public injecting and the need for ‘safer environment interventions’ in the reduction of drug-related harm. Addiction, 101(10), 1384–1393.PubMedCrossRef
Rhodes, T., Singer, M., Bourgois, P., Friedman, S. E., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science & Medicine, 61, 1026–1044.CrossRef
Shlay, J. C., Blackburn, D., O’Keefe, K., Raevsky, C., Evans, M., & Cohn, D. L. (1996). Human immunodeficiency virus seroprevalence and risk assessment of a homeless population in Denver. Sexually Transmitted Diseases, 23, 304–311.PubMedCrossRef
Shumaker, S. A., & Stokols, D. (1982). Residential mobility as a social issue and research topic (USA). Journal of Social Issues, 38, 1–19.
Sluzki, C. E. (1992). Disruption and reconstruction of networks following migration/relocation. Family Systems Medicine, 10, 359–363.CrossRef
Smereck, G. A., & Hockman, E. M. (1998). Prevalence of HIV infection and HIV risk behaviors associated with living place: on-the-street homeless drug users as a special target population for public health intervention. The American Journal of Drug and Alcohol Abuse, 24, 299–319.PubMedCrossRef
Sosin, M., Piliavin, I., & Westerfelt, H. (1990). Toward a longitudinal analysis of homelessness. Journal of Social Issues, 46, 157–174.
Stokols, D., & Shumaker, S. A. (1982). The psychological context of residential mobility and well-being. Journal of Social Issues, 38, 149–171.
Tomas, A., & Dittmar, H. (1995). The experience of homeless women: an exploration of housing histories and the meaning of home. Housing Studies, 10, 493–515.CrossRef
Waltermaurer, E., McNutt, L.-A, & Mattingly, M. J. (2006) Examining the effect of residential change on intimate partner violence risk. Journal of Epidemiology and Community Health, 60(11), 1214–1222.CrossRef
Weitzman, B., Knickman, J., & Shinn, M. (1990). Pathways to homelessness among New York City families. Journal of Social Issues, 46, 125–140.CrossRef
Winstanley, A., Thorns, D. C., & Perkins, H. V. (2002). Moving house, creating home: Exploring residential mobility. Housing Studies, 17, 813–832.CrossRef
Zolopa, A. R., Hahn, J. A., Gorter, R., Miranda, J., Wlodarczyk, D., Peterson, J., et al. (1994). HIV and tuberculosis infection in San Francisco’s homeless adults. Prevalence and risk factors in a representative sample. JAMA, 272, 455–461.PubMedCrossRef
Metadata
Title
Residential Transience and HIV Risk Behaviors Among Injection Drug Users
Authors
Danielle German
Melissa A. Davey
Carl A. Latkin
Publication date
01-11-2007
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 2/2007
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9238-3

Other articles of this Special Issue 2/2007

AIDS and Behavior 2/2007 Go to the issue

Original Paper

Homelessness Prevention: The Effect of a Shallow Rent Subsidy Program on Housing Outcomes among People with HIV or AIDS

Original Paper

Policy Perspective on Housing and HIV/AIDS

Original Paper

Uncovering Patterns of HIV Risk Through Multiple Housing Measures

Original Paper

Safe Living: The Impact of Unstable Housing Conditions on HIV Risk Reduction Among Female Drug Users

Original Paper

Housing Need, Housing Assistance, and Connection to HIV Medical Care

Original Paper

Sexual Risk among Impoverished Women: Understanding the Role of Housing Status
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits